揭示了环境三暴露和慢性病背后的分子机制
Xiangyan Wu1, Ziyi Tan2, Hankun Chen3
1School of Automation, Guangdong University of Technology, Guangzhou, Guangdong 510006, China.
Ecotoxicology and environmental safety
|October 31, 2025
概括
相-3 (BP-3) 暴露与慢性病 (CKD) 通过炎症和代谢途径有关. 像CX3CR1,CXCR4和CCR1这样的关键基因被确定为BP-3诱导的CKD中的核心参与者.
科学领域:
- 环境毒理学环境毒理学
- 脏病理学 脏病理学
- 系统生物学 系统生物学
背景情况:
- 索-3 (BP-3),一种常见的紫外线过器,引发了健康问题.
- 暴露于BP-3的潜在不良影响需要调查.
- 了解BP-3在慢性病 (CKD) 中的作用至关重要.
研究的目的:
- 探索BP-3暴露与CKD之间的关联.
- 为了确定参与BP-3诱导的CKD病变发生的关键基因.
- 为了阐明将BP-3与脏疾病联系起来的分子机制.
主要方法:
- 综合网络毒理学方法.
- 非负矩阵分解和机器学习算法.
- 分子对接和动力学模拟.
主要成果:
- 与BP-3相关的CKD基因在炎症和代谢途径中得到丰富.
- 确定了两种不同的CKD亚型 (C1:炎症主导,C2:代谢主导).
- 确定了三个枢纽基因 (CX3CR1,CXCR4,CCR1);BP-3直接与它们编码的蛋白质结合.
结论:
- 与BP-3相关的CKD涉及炎症和代谢途径的复杂相互作用.
- 对环境污染物诱导的CKD病原体的新型机制性见解.
- 已识别的枢纽基因为CKD风险评估和预防提供了潜在的目标.
相关概念视频
Chronic Kidney Disease I: Introduction
553
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
553
Chronic Kidney Disease III: Interprofessional Care
332
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
332
Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
569
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
569
Acute Kidney Injury II: Pathophysiology
869
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
869
Acute Kidney Injury III: Clinical Manifestations
802
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
802


